Clinical trial Recruiting at 1 site Interventional Ages 22 to 59

Wavefront-guided LASIK versus ray-tracing-guided LASIK in opposite eyes

Official title: A Prospective Randomized Comparison of Wavefront-guided LASIK Surgery to Ray Tracing-Guided LASIK Surgery

Run by Stanford University · NCT07078799 · Data updated 2026-11-12

We will try wavefront-guided LASIK in one eye and ray-tracing-guided LASIK in the other eye of adults 22 and older with nearsightedness (with up to 3 diopters of astigmatism) to see if one gives better vision outcomes.

Quick facts

Study typeInterventional
Ages22 Years to 59 Years
SexAll
Enrollment70 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 22, 2026
Trial IDNCT07078799 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 22 or older with healthy eyes, stable myopia between −1.00 and −10.00 diopters, ≤3.00 diopters of astigmatism, similar prescriptions between eyes, and who are willing to have one eye receive each procedure and attend follow-up visits.

Probably not a fit

Patients with excessively thin corneas, topographic evidence of keratoconus or other ectatic disorders, autoimmune disease, pregnancy or nursing, more than 3.00 D astigmatism, or >1.5 D difference between eyes are unlikely to be eligible or benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized comparison enrolls up to 70 adults with myopia (−1.00 to −10.00 D) and ≤3.00 D astigmatism to receive wavefront-guided LASIK in one eye and ray-tracing-guided LASIK in the fellow eye. Which eye receives which procedure is assigned at random before enrollment, and both procedures are performed according to FDA-approved labeling. Participants undergo preoperative baseline measurements and scheduled postoperative ophthalmic examinations to compare visual outcomes and safety between the two guidance methods. The within-patient design reduces variability by directly comparing both techniques in the same individual.

Why it matters

Potential benefit: If successful, the trial could identify which LASIK guidance method yields sharper vision or fewer side effects, helping patients and surgeons choose the better option.

How similar studies have gone: Both approaches are FDA-approved and wavefront-guided LASIK has extensive prior data while ray-tracing guidance is newer and direct randomized, within-patient comparisons are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 22 and older
2. People with healthy eyes:

   1. No abnormal corneal shape
   2. No excessively thin corneas
   3. No eye diseases such as glaucoma or cataracts
3. Nearsightedness between -1.00 diopters and -10.00 diopters.
4. Subjects with less than or equal to 3.00 diopters of astigmatism.
5. Subjects must have similar levels of nearsightedness in each eye.

Exclusion Criteria:

1. Subjects under the age of 22.
2. Subjects with excessively thin corneas.
3. Subjects with topographic evidence of keratoconus.
4. Subjects with ectactic eye disorders.
5. Subjects with autoimmune diseases.
6. Subjects who are pregnant or nursing at the time of surgery. (The FDA-approved labelling indications for LASIK specifically excludes patients who are pregnant or nursing. There is no strict prohibition not to become pregnant during the one year study period)
7. They can not be more than 1.5 diopter of difference between eyes.
8. Subjects with more than 3.00 diopters of astigmatism
9. Subjects with disimilar levels of astigmatism in each eye (They can not have more than 0.75 diopters of difference between eyes) -

Where it's running

  • Byers Eye Institute at Stanford University School of Medicine
    Palo Alto, California, United States
    Recruiting

Study contacts

  • Principal investigator: Edward E Manche, MD — Stanford University
  • Study coordinator: Edward E Manche, MD
  • Email: cornea@stanford.edu
  • Phone: 650 725 5765

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.